Efficacy and Safety of Zoledronate for Osteopenia and Osteoporosis in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Introduction: Osteopenia and osteoporosis are common among postmenopausal women, significantly increasing fracture risk and reducing bone mineral density (BMD). Zoledronate, a long-acting bisphosphonate, has shown promise in fracture prevention and BMD improvement. However, its efficacy and safety i...
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Gleam Publishing
2025-02-01
|
| Серія: | Journal of Clinical Question |
| Предмети: | |
| Онлайн доступ: | https://jclinque.com/article/efficacy-and-safety-of-zoledronate-for-osteopenia-and-osteoporosis-in-postmenopausal-women-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
